Pharmacokinetics and dose recommendations for cyclosporine and tacrolimus when coadministered with ABT-450, ombitasvir, and dasabuvir.

Pharmacokinetics and dose recommendations for cyclosporine and tacrolimus when coadministered with ABT-450, ombitasvir, and dasabuvir.
复制标题

DOI:
10.1111/ajt.13111
复制
发表时间:
2015-05
期刊:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
影响因子:
--
通讯作者:
Menon R
Menon R
中科院分区:
其他
文献类型:
--
作者:
Badri P;Dutta S;Coakley E;Cohen D;Ding B;Podsadecki T;Bernstein B;Awni W;Menon R

文献摘要

参考文献

被引文献

相似文献

作者描述了丙型肝炎直接作用抗病毒药物 ABT-450、ombitasvir 和 dasabuvir 与环孢素 A 和他克莫司的药物相互作用概况,并使用药代动力学模拟来制定在移植后复发性丙型肝炎感染患者中减少环孢素 A 和他克莫司剂量的建议。
The authors describe the drug–drug interaction profile of the he patitis C direct‐acting antiviral agents ABT‐450, ombitasvir, and dasabuvir with cyclosporine A and tacrolimus, and use pha rmacokinetic simulations to develop recommendations for reduced doses of cyclosporine A and tacrolimus in posttransplant patients with recurrent hepatitis C infection.
DOI: 10.1053/jlts.2003.50171
发表时间: 2003-09-01
影响因子: 4.6
作者:
Jain, AB;Venkataramanan, R;Fung, JJ
通讯作者: Fung, JJ
DOI: 10.1177/0091270006296523
发表时间: 2007-02-01
影响因子: 2.9
作者:
Krishna, Rajesh;Bergman, Arthur;Herman, Gary
通讯作者: Herman, Gary
DOI: 10.1016/j.cld.2007.04.010
发表时间: 2007-05-01
影响因子: 5.1
作者:
Berenguer, Marina
通讯作者: Berenguer, Marina
DOI: 10.1007/s00228-013-1471-2
发表时间: 2013-06-01
影响因子: 2.9
作者:
Nara, Miho;Takahashi, Naoto;Sawada, Kenichi
通讯作者: Sawada, Kenichi
DOI: 10.1016/s1542-3565(05)00709-3
发表时间: 2005-10-01
期刊: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
影响因子: --
作者:
Terrault, Norah A
通讯作者: Terrault, Norah A